Compound: FDB016251 (Iron)
Term: Lumiracoxib Action Pathway
Definition: the mechanism of action of lumiracoxib is thought to be due to its ability to block prostaglandin synthesis by inhibiting cyclooxygenase 2 (cox-2), also called prostaglandin g/h synthase 2. cox-2 catalyze the conversion of arachidonic acid to prostaglandin g2 and prostaglandin g2 to prostglandin h2.
Parent Term: Biochemical pathway
Parent Definition: A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.
Other Compounds Mapped to 'Lumiracoxib Action Pathway'